Chrysa Mineo

CIK 1575644 · SVP, Corporate Development · last filed 2026-01-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

18

Lifetime Open-Market Net

-$3.22M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cidara Therapeutics, Inc. (CDTX) Delisted Director 0 $221.38 $0 $73.9K 12 2026-01-07
Receptos, Inc. (RCPT) Delisted SVP, Corporate Development 0 -$3.29M 6 2015-08-27

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-15 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) $0 EDGAR
2018-03-01 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) $0 EDGAR
2015-08-27 Receptos, Inc. (RCPT) Delisted Mixed −111,692 $0 EDGAR
2015-04-03 Receptos, Inc. (RCPT) Delisted Grant (A) +7,000 $0 EDGAR
2014-11-12 Receptos, Inc. (RCPT) Delisted Sell (S) −30,000 -$3.29M EDGAR
2013-12-26 Receptos, Inc. (RCPT) Delisted Grant (A) $0 EDGAR
2013-07-19 Receptos, Inc. (RCPT) Delisted Grant (A) $0 EDGAR
2013-05-14 Receptos, Inc. (RCPT) Delisted Conv (C) +8,702 $45.7K EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.